> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Pharmacy Compounding Advisory Committee Meeting 9/12
- URL: https://www.fdaweb.com/pharmacy-compounding-advisory-committee-meeting-9-12/
- Published: 2018-07-24T12:00:00.000Z
- Updated: 2026-09-15T00:21:27.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5141942

*Federal Register* notice: FDA has announced a 9/12 Pharmacy Compounding Advisory Committee meeting. Panel members will receive information on balancing the criteria for 503A bulk drug substance evaluation and compounding as it relates to dietary supplements. In addition, the committee will discuss six bulk drug substances nominated for inclusion on the 503A Bulks List — alpha lipoic acid, coenzyme Q10, creatine monohydrate, pyridoxal 5 phosphate, choline chloride, and quercetin. To view the notice, click [here](https://www.gpo.gov/fdsys/pkg/FR-2018-07-24/pdf/2018-15782.pdf?ref=fdaweb.com).